chapter 23 spring 2005 presented by: tiffany marie thoren molecular cell physiology dr. james...
TRANSCRIPT
Chapter 23Chapter 23
Spring 2005Spring 2005Presented by: Tiffany Marie ThorenPresented by: Tiffany Marie Thoren
Molecular Cell PhysiologyMolecular Cell PhysiologyDr. James Enderby BidlackDr. James Enderby Bidlack
CancerCancer
Regulation of cells is lost.Regulation of cells is lost. Decreased or non-existant apoptosisDecreased or non-existant apoptosis
??? Cancer ?????? Cancer ???
EveryoneEveryone• MalesMales• FemalesFemales
Who is Affected?Who is Affected?
Diagnosis of CancerDiagnosis of Cancer
BenignBenign MalignantMalignant
•Possibility of metastatic tumorsPossibility of metastatic tumors
Metastasis AnimationMetastasis Animation
Metastatic TumorsMetastatic Tumors Major cause of treatment failure for Major cause of treatment failure for
cancer patientscancer patients
30% patients have detectable metastases 30% patients have detectable metastases at the diagnosis of primary tumorat the diagnosis of primary tumor
30% patients have micrometastases at 30% patients have micrometastases at the diagnosis of primary tumorthe diagnosis of primary tumor
Treatment ofTreatment ofMetastatic TumorsMetastatic Tumors
Local TreatmentLocal Treatment• Surgery, Radiation, PDT, etc.Surgery, Radiation, PDT, etc.
Lack of Systemic Effect and Tumor RecurrenceLack of Systemic Effect and Tumor Recurrence Can Stimulate Growth of Distant MetastasesCan Stimulate Growth of Distant Metastases
Systemic TreatmentSystemic Treatment • Chemotherapy & ImmunotherapyChemotherapy & Immunotherapy
Known side effect and recurrenceKnown side effect and recurrence No vaccine available - lack of a ubiquitous tumor No vaccine available - lack of a ubiquitous tumor
antigenantigen Use of Immunoadjuvant - lack of tumor specificityUse of Immunoadjuvant - lack of tumor specificity
CombinationCombinationChemotherapyChemotherapy
Administration of Different Drugs Administration of Different Drugs • in sequence, or at the same timein sequence, or at the same time• in different dosesin different doses
Possible Mechanism -- SynergismPossible Mechanism -- Synergism• One treatment may be more effective at One treatment may be more effective at
a certain stage of cancer than anothera certain stage of cancer than another• One treatment modality may enhance One treatment modality may enhance
the effectiveness of another treatment the effectiveness of another treatment modalitymodality
Laser ImmunotherapyLaser Immunotherapy Components:Components:
Laser, Laser-Absorbing Dye, ImmunoadjuvantLaser, Laser-Absorbing Dye, Immunoadjuvant Application:Application:
Intratumor Administration of Dye and AdjuvantIntratumor Administration of Dye and Adjuvant Non-Invasive Laser IrradiationNon-Invasive Laser Irradiation
Results:Results: Eradication of TumorsEradication of Tumors Long-Term Tumor ResistanceLong-Term Tumor Resistance
Mechanism - Tandem Effect of Two Mechanism - Tandem Effect of Two Interactions -- SynergyInteractions -- Synergy
Dye-Enhanced Selective Photothermal ReactionDye-Enhanced Selective Photothermal Reaction Adjuvant-Regulated Immunological ReactionAdjuvant-Regulated Immunological Reaction
Treatment ofTreatment ofPrimary TumorPrimary Tumor
-2
0
2
4
6
8
10
12
14
16
18
20
0 10 20 30 40 50 60 70 80 90 100
Tumor Implantation (days)
Tu
mo
r B
urd
en (
cm3 )
Laser-ICG-GC Treated
Primary Tumor of Control Rat
Tre
atm
ent
Death
Survival Rate afterSurvival Rate afterImmunotherapy TreatmentImmunotherapy Treatment
0
20
40
60
80
100
0 20 40 60 80 100 120
Tumor Implantation (Days)
Su
rviv
al R
ate
(%)
Controls (20 rats)
Laser-ICG-GC (16 rats)
Laser ImmunotherapyLaser Immunotherapy
Effect of Laser ImmunotherapyEffect of Laser Immunotherapy• On Treated Primary TumorsOn Treated Primary Tumors• On Untreated MetastasesOn Untreated Metastases• Long-Term SurvivalLong-Term Survival• Tumor ResistanceTumor Resistance• Detected Immune responsesDetected Immune responses
Advantages:Advantages:• Local ApplicationLocal Application• Systemic EffectSystemic Effect• Long-Term EffectLong-Term Effect• In-SituIn-Situ Vaccination Vaccination
Laser ImmunotherapyLaser Immunotherapy
Possible Mechanism-- Possible Mechanism-- Tandem EffectTandem Effect• Acute Selective Photothermal EffectAcute Selective Photothermal Effect
Eradication of the tumor Eradication of the tumor Possible Antigen exposurePossible Antigen exposure
• Immunological EffectImmunological Effect Combination of Immunoadjuvant and Liberated Combination of Immunoadjuvant and Liberated
Tumor AntigensTumor Antigens Stimulate and Direct the Host Immune System Stimulate and Direct the Host Immune System
Against remaining tumor cells both locally and in Against remaining tumor cells both locally and in remote metastatic sitesremote metastatic sites
• An in situ Vaccination against the TumorAn in situ Vaccination against the Tumor
THANKTHANKYOUYOUQuestions?Questions?